GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

Home・Listă Acțiuni・BioArctic AB

B
BioArctic AB

Închisă

284.6 -2.47

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

284.2

Maxim

285.2

Indicatori cheie
By Trading Economics
Venit	-896M 179M
Vânzări	-897M 392M
P/E Medie Sector	23.701 35.69
EPS	1.09
Marjă de profit	45.668
Angajați	119
EBITDA	-893M 188M

Statistici piață
By TradingEconomics
Capitalizare de piață	4.5B 25B
Deschiderea anterioară	287.07
Închiderea anterioară	284.6

BioArctic AB Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

26 sept. 2025, 18:25 UTC

Principalele dinamici ale pieței

Mirion Technologies Stock Rises on Expanded Notes, Shares Offerings

27 sept. 2025, 07:00 UTC

Câștiguri

This Water Stock Is Dehydrated. What Could Bring It Back. -- Barrons.com

27 sept. 2025, 04:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

26 sept. 2025, 21:56 UTC

Achiziții, Fuziuni, Preluări

Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors -- Barrons.com

26 sept. 2025, 20:54 UTC

Câștiguri

U.S. TikTok for $14 Billion? Making Sense of the Bargain-Basement Price. -- Barrons.com

26 sept. 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

26 sept. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

26 sept. 2025, 20:27 UTC

Achiziții, Fuziuni, Preluări

Electronic Arts Stock Pops on Report Videogame Maker Is Close to Going Private -- Barrons.com

26 sept. 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

26 sept. 2025, 19:54 UTC

Market Talk

Canada's Can't-Build Reputation Is Somewhat Earned -- Market Talk

26 sept. 2025, 19:53 UTC

Achiziții, Fuziuni, Preluări

Electronic Arts Stock Pops on Report Videogame Maker Is Close to Going Private -- Barrons.com

26 sept. 2025, 19:40 UTC

Câștiguri

The U.S. TikTok Is Apparently Fetching a Bargain-Basement Price. A Few Reasons Why. -- Barrons.com

26 sept. 2025, 19:24 UTC

Market Talk

U.S. Natural Gas Futures Mixed As October Expires -- Market Talk

26 sept. 2025, 19:17 UTC

Market Talk

Oil Posts Weekly Gains on Russia-Ukraine Tensions -- Market Talk

26 sept. 2025, 19:15 UTC

Market Talk

AI Deployment Beginning to Weigh on Job Creation, Former Central Banker Says -- Market Talk

26 sept. 2025, 19:03 UTC

Market Talk

Global Equities Roundup: Market Talk

26 sept. 2025, 19:03 UTC

Market Talk

Gold Fuels Stellar Performance in Toronto Stock Market -- Market Talk

26 sept. 2025, 18:50 UTC

Market Talk

Câștiguri

Costco's Executive Membership Gains Seen as Offsetting Slower Renewal Rates -- Market Talk

26 sept. 2025, 18:36 UTC

Market Talk

Silver Closes Out Week With Strong Surge -- Market Talk

26 sept. 2025, 18:02 UTC

Achiziții, Fuziuni, Preluări

ING: Continue Working Towards Completing Transaction, Exit From Russian Market >ING

26 sept. 2025, 18:02 UTC

Achiziții, Fuziuni, Preluări

ING: Global Development Hasn't Received All Necessary Approvals >ING

26 sept. 2025, 18:02 UTC

Achiziții, Fuziuni, Preluări

ING: No Realistic Prospect of Completing Sale of ING Bank (Eurasia) to Global Development in 3Q

26 sept. 2025, 17:54 UTC

Market Talk

U.S. Oil Rig Count Rises For Fifth Straight Week -- Market Talk

26 sept. 2025, 16:56 UTC

Market Talk

Câștiguri

Costco Increasingly Challenged to Meet Lofty Expectations -- Market Talk

26 sept. 2025, 16:41 UTC

Market Talk

Câștiguri

Costco's Valuation Seen as Too High Amid Slow Down -- Market Talk

26 sept. 2025, 16:26 UTC

Câștiguri

Correction to Sherwin-Williams Extends Losses. What's Ailing the Paint Maker. -- Barrons.com

26 sept. 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

26 sept. 2025, 16:12 UTC

Market Talk

Nike Stock Seen With Limited Upside -- Market Talk

26 sept. 2025, 15:59 UTC

Market Talk

Global Equities Roundup: Market Talk

26 sept. 2025, 15:59 UTC

Market Talk

Nike Seen Showing Progress in Turnaround -- Market Talk

Comparație

Modificare preț

BioArctic AB Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.